Urotensin II: a New Mediator in Cardiopulmonary Regulation?
Overview
Authors
Affiliations
Garoufi A, Drapanioti S, Marmarinos A, Askiti V, Mitsioni A, Mila M BMC Nephrol. 2017; 18(1):113.
PMID: 28359257 PMC: 5374664. DOI: 10.1186/s12882-017-0530-9.
The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification.
Albanese I, Daskalopoulou S, Yu B, You Z, Genest J, Alsheikh-Ali A Front Pharmacol. 2016; 7:149.
PMID: 27375483 PMC: 4894881. DOI: 10.3389/fphar.2016.00149.
Urotensin-II: More Than a Mediator for Kidney.
Balat A, Buyukcelik M Int J Nephrol. 2012; 2012:249790.
PMID: 23094156 PMC: 3474241. DOI: 10.1155/2012/249790.
Kidney is in trouble with mediators.
Balat A Bosn J Basic Med Sci. 2010; 10 Suppl 1:S29-36.
PMID: 20433427 PMC: 5627709. DOI: 10.17305/bjbms.2010.2643.
Urotensin-II levels in children with minimal change nephrotic syndrome.
Balat A, Pakir I, Gok F, Anarat R, Sahinoz S Pediatr Nephrol. 2004; 20(1):42-5.
PMID: 15602665 DOI: 10.1007/s00467-004-1716-5.